Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review

GlobalData
39 Pages - GLDATA68684
$125.00

Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Yuhan Corp (Yuhan) is a research based company that develops, manufactures and markets pharmaceutical products. It offers APIs and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. The company offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. Yuhan provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. The company offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Yuhan Corp Key Recent Developments

Jul 02,2019: Boehringer partners with Yuhan for liver disease drug
Nov 05,2018: Yuhan licences lung cancer asset to Janssen in $1.25bn deal

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Yuhan Corp - Key Facts
Yuhan Corp - Key Employees
Yuhan Corp - Major Products and Services
Yuhan Corp - History
Yuhan Corp - Company Statement
Yuhan Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 – Company Analysis
Company Overview
Yuhan Corp - Business Description
R&D Overview
Yuhan Corp - Corporate Strategy
Yuhan Corp - SWOT Analysis
SWOT Analysis - Overview
Yuhan Corp - Strengths
Yuhan Corp - Weaknesses
Yuhan Corp - Opportunities
Yuhan Corp - Threats
Yuhan Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Yuhan Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 02, 2019: Boehringer partners with Yuhan for liver disease drug
Nov 05, 2018: Yuhan licences lung cancer asset to Janssen in $1.25bn deal
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Yuhan Corp, Key Facts
Yuhan Corp, Key Employees
Yuhan Corp, Major Products and Services
Yuhan Corp, History
Yuhan Corp, Other Locations
Yuhan Corp, Subsidiaries
Yuhan Corp, Affiliate
Yuhan Corp, Joint Venture
Yuhan Corp, Key Competitors
Yuhan Corp, Ratios based on current share price
Yuhan Corp, Annual Ratios
Yuhan Corp, Annual Ratios (Cont...1)
Yuhan Corp, Annual Ratios (Cont...2)
Yuhan Corp, Interim Ratios
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Yuhan Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Yuhan Corp, Performance Chart (2014 - 2018)
Yuhan Corp, Ratio Charts
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838